metastatic brain cancer
Showing 1 - 25 of >10,000
DevelopingNew MRI Technique to Understand Changes in Brain
Recruiting
- Brain Metastases
- +3 more
- CEST-MRF
-
New York, New YorkMemorial Sloan Kettering Cancer Center (All Protocol Activities)
Sep 27, 2022
HER2-positive Breast Cancer, LMD Trial (Tucatinib 150 MG, Trastuzumab, Capecitabine)
Not yet recruiting
- HER2-positive Breast Cancer
- LMD
- Tucatinib 150 MG
- +3 more
- (no location specified)
Aug 24, 2023
Breast Cancer Trial in Xi'an (Inetetamab plus pyrotiniband and capecitabine)
Active, not recruiting
- Breast Cancer
- Inetetamab plus pyrotiniband and capecitabine
-
Xi'an, Shaanxi, ChinaXi'an International Medical Center Hospital
Aug 27, 2023
Metastatic Breast Cancer, Brain Metastases Trial in Tampa (Nivolumab, Stereotactic Radiosurgery)
Active, not recruiting
- Metastatic Breast Cancer
- Brain Metastases
- Nivolumab
- Stereotactic Radiosurgery
-
Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
Nov 17, 2022
Metastatic Breast Cancer, Advanced Non-Small Cell Squamous Lung Cancer, Solid Tumor, Adult Trial (Patritumab deruxtecan)
Not yet recruiting
- Metastatic Breast Cancer
- +2 more
- Patritumab deruxtecan
- (no location specified)
May 9, 2023
Brain Cancer, Glioblastoma, Metastatic Cancer Trial in New York (Trastuzumab deruxtecan)
Recruiting
- Brain Cancer
- +4 more
- Trastuzumab deruxtecan
-
New York, New YorkMemorial Sloan Kettering Cancer Center (All Protocol Activities)
Sep 22, 2023
Metastatic Breast Cancer Trial in New York (Brain radiotherapy or Stereotactic Radiosurgery, Tremelimumab, HER2 directed
Completed
- Metastatic Breast Cancer
- Brain radiotherapy or Stereotactic Radiosurgery
- +3 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Aug 2, 2022
Metastatic HER2 Negative Breast Carcinoma, Brain Metastases, Capecitabine Trial in Changsha (UTD1 combined with capecitabine)
Recruiting
- Metastatic HER2 Negative Breast Carcinoma
- +3 more
- UTD1 combined with capecitabine
-
Changsha, ChinaQuchang Ouyang
Sep 9, 2022
Rurality Adapted Physical Activity Sport Health
Not yet recruiting
- Brain Tumour
- Metastatic Cancer
- Adapted physical activity at home
-
Angers, FranceInstitut de Cancerologie de L'Ouest
Jul 31, 2023
NSCLC, Non-small Cell Carcinoma, Histiocytic Tumor Trial (BDTX-4933)
Not yet recruiting
- Non-small Cell Lung Cancer
- +32 more
- (no location specified)
Mar 30, 2023
Breast Cancer, Metastatic Breast Cancer Trial (Trastuzumab-Deruxtecan (T-DXd))
Not yet recruiting
- Breast Cancer
- Metastatic Breast Cancer
- Trastuzumab-Deruxtecan (T-DXd)
- (no location specified)
Sep 20, 2023
Metastatic Breast Cancer Trial in Zhengzhou (SHR-A1811, Pyrotinib, Bevacizumab)
Not yet recruiting
- Metastatic Breast Cancer
- SHR-A1811
- +2 more
-
Zhengzhou, Henan, ChinaHenan Cancer Hospital
Mar 13, 2023
Non Small Cell Lung Cancer Metastatic Trial (MRI)
Not yet recruiting
- Non Small Cell Lung Cancer Metastatic
- MRI
- (no location specified)
May 16, 2023
Protein Kinase Inhibitors, Other Protocol Specified Criteria, Lung Tumors Trial in Guangzhou (JYP0322)
Recruiting
- Protein Kinase Inhibitors
- +3 more
-
Guangzhou, Guangdong, ChinaSun Yat-Sen University Cancer Center
Nov 9, 2023
Repository in Adults Diagnosed With Primary and Metastatic Brain
Not yet recruiting
- Brain Tumor, Primary
- Brain Metastases, Adult
-
Durham, North CarolinaDuke Cancer Center
Jul 27, 2022
Metastatic Lung Non-Small Cell Carcinoma, Metastatic Malignant Tumor in the Brain, Stage IV Lung Cancer AJCC v8 Trial in Duarte
Not yet recruiting
- Metastatic Lung Non-Small Cell Carcinoma
- +2 more
- Biospecimen Collection
- +4 more
-
Duarte, CaliforniaCity of Hope Medical Center
May 1, 2023
Brain Metastases, HR+ Metastatic Breast Cancer Trial in Tampa (Stereotactic Radiosurgery (SRS), Abemaciclib, Endocrine therapy)
Recruiting
- Brain Metastases
- HR+ Metastatic Breast Cancer
- Stereotactic Radiosurgery (SRS)
- +2 more
-
Tampa, FloridaMoffitt Cancer Center
Nov 1, 2022
Metastatic Breast Cancer Trial in New York (Tucatinib)
Recruiting
- Metastatic Breast Cancer
-
New York, New YorkMemorial Sloan Kettering Cancer Center
May 26, 2023
Non Small Cell Lung Cancer Metastatic, Brain Metastases, Adult, KRAS G12C Trial (JDQ443)
Not yet recruiting
- Non Small Cell Lung Cancer Metastatic
- +2 more
- (no location specified)
Aug 11, 2023
Metastatic NSCLC MET Exon 14 Skipping Mutation and Brain
Completed
- Metastatic Non-Small Cell Lung Cancer
-
East Hanover, New Jersey18 Novartis Investigative Sites in the US
Dec 29, 2022
Anatomic Stage IV Breast Cancer AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Glioma Trial in Los Angeles (Computed
Recruiting
- Anatomic Stage IV Breast Cancer AJCC v8
- +19 more
- Computed Tomography
- +3 more
-
Los Angeles, CaliforniaUSC / Norris Comprehensive Cancer Center
Aug 19, 2022
Lung Cancer, Lung Cancer Metastatic, Brain Metastases Trial in Sacramento ([18F]-avß6-BP)
Recruiting
- Lung Cancer
- +3 more
-
Sacramento, CaliforniaThe University of California Davis Comprehensive Cancer Center
Aug 3, 2022
Breast Cancer, HER2-positive Breast Cancer, Triple Negative Breast Cancer Trial in Boston (MRI)
Recruiting
- Breast Cancer
- +5 more
- MRI
-
Boston, MassachusettsBrigham and Women's Hospital
Dec 9, 2022
Brain Metastases Trial in Oslo (diagnostic test, radiation, drug)
Active, not recruiting
- Brain Metastases
- Magnetic Resonance Imaging
- +2 more
-
Oslo, NorwayOslo University Hospital
Sep 20, 2022
Metastatic Solid Tumor, Brain Metastases Trial in Houston (Trastuzumab emtansine, Tucatinib)
Not yet recruiting
- Metastatic Solid Tumor
- Brain Metastases
- Trastuzumab emtansine
- Tucatinib
-
Houston, TexasM D Anderson Cancer Center
Dec 30, 2022